SoftGenetics has signed a strategic agreement with Elsevier to integrate Elsevier's Pathway Studio with its NextGene software.
The combined solution will provide customers with an integrated workflow for analyzing next-generation sequence data that covers genome alignment through to differential gene expression analysis and biological pathway analysis based on curated information from scientific literature.
"Our goal is to ensure that our customers quickly and easily find evidence and data that is relevant and authoritative … [and] our collaboration with SoftGenetics meets this goal," Jaqui Hodgkinson, Elsevier's vice president of product development for biology products, said in a statement. "This integration will reduce their workload, reduce complexity, and increase the accuracy of their analysis."
"Our collaboration extends the functionality of both SoftGenetics' NextGene software and Elsevier's products," Kevin LeVan, SoftGenetics' product manager for NextGene, added. "With NextGene and Pathway Studio's software integration, our customers now have a streamlined process to go from high-throughput sequencing to identifying relevant pathways."